Torsten Vahl
Latest contributions
Key questions in aortic valve intervention - What are the surgical and transcatheter treatment options for patients with severe aortic regurgitation?
21 Nov 2023 – From PCR London Valves 2023
Although aortic regurgitation is highly prevalent, it remains under-diagnosed and under-treated. Fortunately, the latest devices should rapidly reverse this trend, both surgically and through transcatheter treatments. Find out more about the options available today, whether surgical or transcatheter, with their benefits and limitations, and how to choose them...
Aortic regurgitation - Part 1
20 Nov 2023 – From PCR London Valves 2023
Delve into key insights on aortic regurgitation with this selection of abstracts: explore a systematic review and meta-analysis on TAVI for aortic regurgitation using dedicated devices, witness video-densitometric analysis of aortic regurgitation post-JenaValve Trilogy treatment, discover a small case series on TAVI in the descending thoracic...
Treatment of multi-valve disease
29 Nov 2022 – From PCR London Valves 2022
Get a look at these presentations to learn more about the basic haemodynamic interactions between different valve lesions, the existing surgical standards (and evolving transcatheter standards) for the treatment of multi-valve disease, and to discover a selection of cases that demonstrate the importance of clear indications and appropriate timing...
TAVI: technical considerations
28 Nov 2022 – From PCR London Valves 2022
Consult this session on TAVI technical considerations to discover a selection of cases presented during PCR LV 2022: transseptal snaring as a bailout from valvuloplasty balloon entrapment within a self-expanding valve, severe thrombocytopenia and severe aortic stenosis, embolisation of a fully deployed Evolute valve due to chest...
TAVI innovations
27 Nov 2022 – From PCR London Valves 2022
Discover some of the latest innovations in TAVI presented at PCR LV 2022: zero-contrast TAVI, emerging technique for coronary protection in ViV TAVR, first dedicated splitting device in a degenerated TAVR at risk for double coronary obstruction, and much more!
A new evolution: TAVR for aortic regurgitation with the JenaValve Trilogy System
22 Nov 2021 – From PCR London Valves
Watch this session released during PCR London Valves 2021 Congress to have a deep dive into aortic regurgitation: the natural history, the clinical reality of it, and a fantastic live recorded case, so as to gain deeper understanding of the progression of severe aortic regurgitation, to learn more...
EuroPCR 2021 - Innovations in mitral valve replacement and repair
18 May 2021 – From EuroPCR 2021
In this session, get a clear presentation of the SATURN device, its procedure and its early results, and a good demonstration of the successful transseptal deployment of this implant in the acute porcine model.
Case-based learning for the Heart Valve Team: TAVI in pure aortic regurgitation
19 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI in pure aortic regurgitation to learn more about the anatomy and pathophysiology of aortic regurgitation, the current and emerging surgical treatment options, and the potential role of TAVI in this patient group and how to identify potential candidates for transcatheter intervention.
Introduction to the PCR London Valves 2019 Aortic Track - The key questions in TAVI: where are we in 2019?
18 Nov 2019 – From PCR London Valves 2019
Consult this session on the key questions in TAVI to learn more about the challenges, the latest evidence addressing the unresolved questions (durability, concomitant CAD, reaccess, asymptomatic AS...) and how to apply this information in your daily clinical practice.
TAVI: clinical outcomes with new devices and delivery systems
18 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI to learn more about the clinical outcomes with new devices and delivery systems, such as the self-expandable Portico valve, the Portico IDE FlexNav delivery system, the SAPIEN 3 Ultra system, and more!
